Boston Sci Scraps Majority Stake Deal with M.I. Tech

Boston Scientific is scrapping its original plan to buy a majority stake in M.I. Tech, a Korean surgical tools company, for $230 million. Instead, the company will purchase a minority stake of around 10% that will go through later in 2023. Boston Sci put the change of plans down to an inability to obtain required global regulatory approvals in some countries.